ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Nixon Tells ACCC U.S., USSR Should Be Allies In War Against Cancer

April 11, 1986

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

“Of Sofas and Chairs” at MD Anderson: Official Seeks Protection from “Losers,” Explains Costly Interior Design Choices

June 7, 2013

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

January 19, 1996